Analysis of the Irrational Clinical Application of Chinese Patent Medicine and Policy Recommendations

Chinese Journal of Pharmacovigilance ›› 2011, Vol. 8 ›› Issue (10): 606-607.

Previous Articles Next Articles

Analysis of the Irrational Clinical Application of Chinese Patent Medicine and Policy Recommendations

DANG Hai-xia¹, WANG Hai-nan^{2, *}

1 The Development and Research Centre on TCM, China Academy of Chinese Medical Science, Beijing 100700, China;
2 State Food and Drug Administration, Beijing 100053, China

Received:2010-02-20 Online:2011-10-10 Published:2015-07-30

Abstract

CLC Number:

R286

DANG Hai-xia, WANG Hai-nan. Analysis of the Irrational Clinical Application of Chinese Patent Medicine and Policy Recommendations[J]. Chinese Journal of Pharmacovigilance, 2011, 8(10): 606-607.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2011/V8/I10/606

[1]	LIU Yiyu, LI Yanwen, WANG Jiao, ZHOU Wenjing, PENG Yumeng, HE Wenbin, LI Zhiyong. Efficacy Semantic Mining and Safety Analysis of Chinese Patent Medicines for Headache [J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 674-679.
[2]	YANG Jingqi, XU Baohai, ZHANG Jing, JIANG Yang, SHI Fang. Pharmacovigilance for Traditional Chinese Patent Medicines for Orthopedics [J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 436-441.
[3]	WANG Han, WANG Cunxuan, LYU Xuehaiyue, ZHANG Lining, SUO Yusi, GU Zhi'en, WANG Ping, JIN Xuejing. Chinese Patent Medicines for Preventing Myelosuppression in Adjuvant Treatment of Malignant Tumors: a Systematic Review and Network Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 169-176.
[4]	YU Xin, GONG Leilei, YAO Weijie, YUAN Sisi, FENG Xin. Chinese patent medicines for recurrent spontaneous abortion: a scoping review of clinical evidence [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 361-365.
[5]	LIU Jie, ZHANG Jianmin, ZHANG Xiaomeng, LIU Fang, SONG Yuan, ZHONG Xuli. Management of risks to pediatric medications based on drug instructions of Chinese patent medicines in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 422-427.
[6]	QIAO Meng, LEI Chao, CHEN Zijia, ZHANG Qiang, WANG Zhifei. Analysis and thinking on the status quo of safety item information in the instructions of traditional Chinese patent medicines containing Asari Radix et Rhizoma and its extracts [J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1401-1406.
[7]	MA Bingbing, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian, LYU Jintao. Consideration of rational use of traditional Chinese medicine and pharmaceutical services for the elderly based on literature analysis [J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 595-599.
[8]	ZHANG Ruili, SU Shuang, JIANG Jiming, ZHANG Jing. Thirty-six cases of adverse drug reactions/events caused by Xinhuang tablets [J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 561-563.
[9]	XIAO Wangzhong, LIN Cong, HUANG Li, DAI Bing, GAO Yuanfeng. Contraindications in package inserts of Chinese patent medicine [J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 400-403.
[10]	LI Ling, LIU Yanmei, TAN Jing, WANG Wen, YAO Minghong, MA Yu, LUO Xiaochao, LIAO Xing, LIU Yan, SONG Haibo, WEN Zehuai, SUN Xin. Developing a safety assessment model for Chinese patent medicines based on real-world data [J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 18-22.
[11]	LIAO Caiyun, LI Yiyun, YAO Wenbing, WEN Baoshu. Dissemination Processes of the Chinese Orange Book: An Empirical Study [J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 810-812.
[12]	ZHOU Sha, YANG Hongjun, JING Zhiwei, LI Geng. Safety Information in Oral Chinese Patent Medicine Instructions for Big Brand Traditional Chinese Medicine [J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 981-985.
[13]	ZHU Lan, Shao Bo, XIA Dongsheng. Selection and Switch-to-OTC of Chinese Patent Medicines in China [J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 785-789.
[14]	WANG Yu,LIN Zhi-jian ,WANG Xiao, CHU Meng-zhen,ZHANG Bing. Analysis and Pharmacovigilance Thinking on Chinese Patent Medicine Containing Psoraleae Fructus [J]. Chinese Journal of Pharmacovigilance, 2018, 15(5): 300-303.
[15]	JI Yue, WANG Tuo-ran, ZHANG Ke-xin, ZHOU Zi-jun, LIU Yu-xuan. Literature Analysis of the Regularity and Adverse Reaction of Cinnamon and Its Prescription Preparations [J]. Chinese Journal of Pharmacovigilance, 2018, 15(3): 163-168.

Analysis of the Irrational Clinical Application of Chinese Patent Medicine and Policy Recommendations

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics